BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3553800)

  • 21. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity.
    Hoft DF; Tennant JM
    Ann Intern Med; 1999 Jul; 131(1):32-6. PubMed ID: 10391813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leprosy and tuberculosis vaccine design.
    Kaufmann SH
    Trop Med Parasitol; 1989 Sep; 40(3):251-7. PubMed ID: 2482532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in tuberculin hypersensitivity following BCG vaccination and the effect of repeated tuberculin tests].
    Tokuchi S; Mori T
    Kekkaku; 1983 Jul; 58(7):395-400. PubMed ID: 6656073
    [No Abstract]   [Full Text] [Related]  

  • 24. Bettering BCG.
    Lancet; 1992 Feb; 339(8791):462-3. PubMed ID: 1346823
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategy for leprosy control.
    Lagrange PH; Stach JL
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):278-88. PubMed ID: 4020217
    [No Abstract]   [Full Text] [Related]  

  • 26. Towards a vaccine against leprosy.
    Sengupta U
    Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection.
    Shield MJ; Stanford JL; Paul RC; Carswell JW
    J Hyg (Lond); 1977 Jun; 78(3):331-48. PubMed ID: 266538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of prior BCG vaccination programmes in the community on the protective efficacy of new antileprosy vaccines.
    Radhakrishna S; Nair NG; Kumar BK; Jayabal P
    Indian J Med Res; 1988 Aug; 88():197-208. PubMed ID: 3058589
    [No Abstract]   [Full Text] [Related]  

  • 29. [Delayed-type hypersensitivity and caseous necrosis in tuberculous granuloma. New ideas for the design of a new vaccine against human tuberculosis].
    Cardona PJ; Ausina V
    Med Clin (Barc); 2000 Oct; 115(13):503-9. PubMed ID: 11093873
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential application of molecular biology to leprosy research.
    Gillis TP
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):591-2. PubMed ID: 10347585
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the efficacy of candidate vaccines against M. leprae infection in mice.
    Sreevatsa ; Desikan KV
    Indian J Lepr; 1988 Apr; 60(2):252-9. PubMed ID: 3192974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern vaccines. Mycobacterial diseases.
    Fine PE; Rodrigues LC
    Lancet; 1990 Apr; 335(8696):1016-20. PubMed ID: 1970071
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.
    Orme IM
    Infect Immun; 1988 Dec; 56(12):3310-2. PubMed ID: 3141288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atopic disease and immunologic response.
    Duffy D
    Science; 1997 Apr; 276(5309):17; author reply 18-9. PubMed ID: 9122695
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacteria and bacterial vaccines as nonspecific modulators of immunological reactivity].
    Prilepin NA; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):5-11. PubMed ID: 7004007
    [No Abstract]   [Full Text] [Related]  

  • 36. Venezuela results and after.
    Gupte MD
    Indian J Lepr; 1992; 64(4):451-9. PubMed ID: 1308519
    [No Abstract]   [Full Text] [Related]  

  • 37. The specificity of a tuberculin devoid from cross-reacting antigens common with BCG, in eliciting the delayed hypersensitivity in men.
    Claiciu I; Stavri D; Bărbulescu R; Algeorge G; Calciu B; Calciu M; Stavri H; Niculescu D
    Arch Roum Pathol Exp Microbiol; 1980; 39(4):369-76. PubMed ID: 6164354
    [No Abstract]   [Full Text] [Related]  

  • 38. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin.
    Orme IM; Collins FM
    Cell Immunol; 1984 Mar; 84(1):113-20. PubMed ID: 6421492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A; Bapat CV
    Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
    Vallishayee RS; Anantharaman DS; Gupte MD
    Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.